22 | Analgesics (Analgesic Drugs)IBA
01/2022
-
12/2006 |
15 | EndocannabinoidsIBA
11/2017
-
12/2006 |
13 | Iodoacetic AcidIBA
04/2024
-
11/2011 |
12 | CannabinoidsIBA
09/2017
-
02/2002 |
10 | CarrageenanIBA
11/2020
-
08/2003 |
6 | LipidsIBA
02/2024
-
04/2013 |
5 | fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA
10/2012
-
12/2006 |
4 | anandamide (arachidonylethanolamide)IBA
04/2024
-
07/2008 |
4 | Opioid Analgesics (Opioids)IBA
04/2024
-
11/2021 |
4 | CB2 Cannabinoid ReceptorIBA
01/2013
-
11/2004 |
3 | 14,15-dihydroxyeicosatrienoic acidIBA
04/2024
-
01/2022 |
3 | AcidsIBA
04/2024
-
09/2014 |
3 | OxylipinsIBA
04/2024
-
01/2018 |
3 | salicylhydroxamic acid (SHAM)IBA
11/2022
-
11/2004 |
3 | Nerve Growth Factor (NGF)IBA
10/2022
-
09/2014 |
3 | CollagenIBA
01/2021
-
06/2015 |
3 | TropomyosinIBA
01/2020
-
09/2014 |
3 | Phosphotransferases (Kinase)IBA
01/2020
-
09/2014 |
3 | CB1 Cannabinoid Receptor (CB1 Receptor)IBA
01/2016
-
08/2003 |
3 | 1,1-dimethylbutyl-1-deoxy-Delta(9)-THCIBA
01/2013
-
11/2004 |
3 | Cannabinoid Receptors (Cannabinoid Receptor)IBA
10/2012
-
01/2008 |
3 | cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA
10/2012
-
07/2008 |
3 | Cannabinoid Receptor AgonistsIBA
12/2005
-
02/2002 |
2 | Glial Fibrillary Acidic ProteinIBA
04/2024
-
03/2019 |
2 | Pain-FreeIBA
04/2024
-
03/2019 |
2 | Morphine (MS Contin)FDA LinkGeneric
04/2024
-
11/2021 |
2 | Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2022
-
01/2020 |
2 | Epoxide HydrolasesIBA
01/2022
-
01/2018 |
2 | LigandsIBA
11/2021
-
04/2013 |
2 | Calcitonin Gene-Related PeptideIBA
11/2020
-
06/2015 |
2 | Messenger RNA (mRNA)IBA
10/2020
-
01/2013 |
2 | Transient Receptor Potential ChannelsIBA
01/2017
-
09/2011 |
2 | Cyclooxygenase 2 (Cyclooxygenase-2)IBA
01/2017
-
07/2008 |
2 | MJN110IBA
11/2016
-
09/2013 |
2 | Capsaicin (Zostrix)FDA Link
01/2016
-
12/2006 |
2 | Diphosphonates (Bisphosphonates)IBA
08/2014
-
01/2011 |
2 | EnzymesIBA
09/2013
-
12/2012 |
2 | CytokinesIBA
01/2013
-
09/2011 |
2 | nimesulide (Aulin)IBA
11/2011
-
07/2008 |
2 | Minocycline (Cyclops)FDA LinkGeneric
11/2011
-
07/2009 |
1 | 8,9-epoxyeicosatrienoic acidIBA
04/2024 |
1 | Arachidonic Acid (Vitamin F)IBA
04/2024 |
1 | 5-hydroxy-6,8,11,14-eicosatetraenoic acidIBA
04/2024 |
1 | Hydroxyeicosatetraenoic Acids (HETE)IBA
04/2024 |
1 | N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
04/2024 |
1 | Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA
02/2024 |
1 | CannabidiolIBA
01/2023 |
1 | Inflammation MediatorsIBA
11/2022 |
1 | Substance PIBA
10/2022 |
1 | EndorphinsIBA
11/2021 |
1 | Naloxone (Narcan)FDA LinkGeneric
11/2021 |
1 | Serine (L-Serine)FDA Link
11/2021 |
1 | Pyruvic Acid (Pyruvate)IBA
01/2021 |
1 | Amino AcidsFDA Link
01/2021 |
1 | Freund's AdjuvantIBA
11/2020 |
1 | LectinsIBA
11/2020 |
1 | Glutamate Receptors (Glutamate Receptor)IBA
11/2019 |
1 | PropionatesIBA
11/2019 |
1 | CalciumIBA
11/2019 |
1 | alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)IBA
11/2019 |
1 | AMPA Receptors (AMPA Receptor)IBA
11/2019 |
1 | 2'-deoxyadenosineIBA
01/2019 |
1 | cordycepinIBA
01/2019 |
1 | mRNA Cleavage and Polyadenylation FactorsIBA
01/2019 |
1 | CRA 013783IBA
11/2018 |
1 | Cathepsin KIBA
11/2018 |
1 | Ala(2)-MePhe(4)-Gly(5)- Enkephalin (DAGO)IBA
01/2018 |
1 | mu Opioid Receptors (mu Opioid Receptor)IBA
01/2018 |
1 | Opioid Peptides (Opioid Peptide)IBA
11/2017 |
1 | Therapeutic UsesIBA
01/2017 |
1 | resolvin D2IBA
01/2017 |
1 | 17- hydroxy- 4,7,10,13,15,19- docosahexaenoic acidIBA
01/2017 |
1 | Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA
01/2017 |
1 | Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
01/2017 |
1 | Triamcinolone Acetonide (Azmacort)FDA LinkGeneric
01/2017 |
1 | Lipase (Acid Lipase)FDA Link
11/2016 |
1 | MonoglyceridesIBA
11/2016 |